PER 4.76% 10.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics Submits Clinical Trial Application For Atl1102 Phase Iib Dmd Trial..., page-19

  1. 2,583 Posts.
    lightbulb Created with Sketch. 333
    That is a great info, almost detective data. Good job.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.